BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 9875847)

  • 1. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
    Shiau AK; Barstad D; Loria PM; Cheng L; Kushner PJ; Agard DA; Greene GL
    Cell; 1998 Dec; 95(7):927-37. PubMed ID: 9875847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
    Greschik H; Flaig R; Renaud JP; Moras D
    J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
    Shiau AK; Barstad D; Radek JT; Meyers MJ; Nettles KW; Katzenellenbogen BS; Katzenellenbogen JA; Agard DA; Greene GL
    Nat Struct Biol; 2002 May; 9(5):359-64. PubMed ID: 11953755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3.
    Greschik H; Wurtz JM; Sanglier S; Bourguet W; van Dorsselaer A; Moras D; Renaud JP
    Mol Cell; 2002 Feb; 9(2):303-13. PubMed ID: 11864604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple mutant of the Drosophila ERR confers ligand-induced suppression of activity.
    Ostberg T; Jacobsson M; Attersand A; Mata de Urquiza A; Jendeberg L
    Biochemistry; 2003 Jun; 42(21):6427-35. PubMed ID: 12767224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma.
    Coward P; Lee D; Hull MV; Lehmann JM
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8880-4. PubMed ID: 11447273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.
    Wärnmark A; Treuter E; Gustafsson JA; Hubbard RE; Brzozowski AM; Pike AC
    J Biol Chem; 2002 Jun; 277(24):21862-8. PubMed ID: 11937504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor.
    Kojetin DJ; Burris TP; Jensen EV; Khan SA
    Endocr Relat Cancer; 2008 Dec; 15(4):851-70. PubMed ID: 18755852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
    Rodriguez AL; Tamrazi A; Collins ML; Katzenellenbogen JA
    J Med Chem; 2004 Jan; 47(3):600-11. PubMed ID: 14736241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
    Métivier R; Penot G; Flouriot G; Pakdel F
    Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communication between the ERRalpha homodimer interface and the PGC-1alpha binding surface via the helix 8-9 loop.
    Greschik H; Althage M; Flaig R; Sato Y; Chavant V; Peluso-Iltis C; Choulier L; Cronet P; Rochel N; Schüle R; Strömstedt PE; Moras D
    J Biol Chem; 2008 Jul; 283(29):20220-30. PubMed ID: 18441008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of bacterially expressed rat estrogen receptor beta ligand binding domain by mass spectrometry: structural comparison with estrogen receptor alpha.
    Witkowska HE; Carlquist M; Engström O; Carlsson B; Bonn T; Gustafsson JA; Shackleton CH
    Steroids; 1997; 62(8-9):621-31. PubMed ID: 9292936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
    Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
    Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
    Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
    J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.
    Wang L; Zuercher WJ; Consler TG; Lambert MH; Miller AB; Orband-Miller LA; McKee DD; Willson TM; Nolte RT
    J Biol Chem; 2006 Dec; 281(49):37773-81. PubMed ID: 16990259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
    Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ
    Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.
    Bramlett KS; Wu Y; Burris TP
    Mol Endocrinol; 2001 Jun; 15(6):909-22. PubMed ID: 11376110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.
    Tamrazi A; Carlson KE; Rodriguez AL; Katzenellenbogen JA
    Mol Endocrinol; 2005 Jun; 19(6):1516-28. PubMed ID: 15661830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer.
    Gowda K; Marks BD; Zielinski TK; Ozers MS
    Anal Biochem; 2006 Oct; 357(1):105-15. PubMed ID: 16889744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.